Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A prospective Japanese study of the association between personality and the progression of lung cancer.

Nagano J, Ichinose Y, Asoh H, Ikeda J, Ohshima A, Sudo N, Kubo C.

Intern Med. 2006;45(2):57-63. Epub 2006 Feb 15.

2.

Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.

Saito-Nakaya K, Nakaya N, Akechi T, Inagaki M, Asai M, Goto K, Nagai K, Nishiwaki Y, Tsugane S, Fukudo S, Uchitomi Y.

Psychooncology. 2008 Sep;17(9):869-76.

PMID:
18033697
3.

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.

Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E.

J Thorac Cardiovasc Surg. 2009 Feb;137(2):425-8. doi: 10.1016/j.jtcvs.2008.05.046. Epub 2008 Aug 29.

4.

Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer.

Akechi T, Okamura H, Okuyama T, Furukawa TA, Nishiwaki Y, Uchitomi Y.

Psychooncology. 2009 Jan;18(1):23-9. doi: 10.1002/pon.1364.

PMID:
18484649
5.

Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study.

Nakaya N, Saito-Nakaya K, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Nagai K, Nishiwaki Y, Fukudo S, Tsubono Y, Uchitomi Y.

Cancer Sci. 2006 Mar;97(3):199-205.

6.
7.

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.

Lung Cancer. 2007 Mar;55(3):263-70. Epub 2007 Jan 17.

PMID:
17207891
8.

Lung cancer, myocardial infarction, and the Grossarth-Maticek personality types: a case-control study in Fukuoka, Japan.

Nagano J, Sudo N, Kubo C, Kono S.

J Epidemiol. 2001 Nov;11(6):281-7. Erratum in: J Epidemiol 2002 Mar;12(2):188.

9.

Negative psychological aspects and survival in lung cancer patients.

Nakaya N, Saito-Nakaya K, Akechi T, Kuriyama S, Inagaki M, Kikuchi N, Nagai K, Tsugane S, Nishiwaki Y, Tsuji I, Uchitomi Y.

Psychooncology. 2008 May;17(5):466-73.

PMID:
17828707
10.

Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.

Sok M, Ravnik J, Ravnik M.

Wien Klin Wochenschr. 2009;121(9-10):314-7. doi: 10.1007/s00508-009-1169-8.

PMID:
19562293
11.
12.

High plasma D-dimer level is associated with decreased survival in patients with lung cancer.

Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T.

Clin Oncol (R Coll Radiol). 2007 Sep;19(7):494-8. Epub 2007 May 21.

PMID:
17513096
13.

Personality and colorectal cancer: the Fukuoka colorectal cancer study.

Nagano J, Kono S, Toyomura K, Mizoue T, Yin G, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N.

Jpn J Clin Oncol. 2008 Aug;38(8):553-61. doi: 10.1093/jjco/hyn067. Epub 2008 Jul 30.

PMID:
18669515
14.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
16.

Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.

Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M.

Thorac Cardiovasc Surg. 2006 Feb;54(1):42-6.

PMID:
16485188
17.

Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.

Lavolé A, Chouaïd C, Baudrin L, Wislez M, Raguin G, Pialoux G, Girard PM, Milleron B, Cadranel J.

Lung Cancer. 2009 Sep;65(3):345-50. doi: 10.1016/j.lungcan.2008.11.018. Epub 2009 Jan 9.

PMID:
19135758
18.

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.

Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M.

Eur J Cancer. 2009 Jul;45(11):1950-8. doi: 10.1016/j.ejca.2009.01.023. Epub 2009 Feb 21.

PMID:
19231158
19.

Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, Whitehead M, Spaans JN, Graham BC, Goss GD; National Cancer Institute of Canada Clinical Trials Group..

J Clin Oncol. 2008 Jan 1;26(1):54-9. doi: 10.1200/JCO.2007.12.8322.

PMID:
18165640
20.

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.

Cancer. 2009 Apr 1;115(7):1507-17. doi: 10.1002/cncr.24128.

Supplemental Content

Support Center